AlloVir Ownership | Who Owns AlloVir?

AlloVir Ownership Summary

AlloVir is owned by 1.43% institutional investors, 49.12% insiders, and 49.45% retail investors. Artal group is the largest institutional shareholder, holding 5.75% of ALVR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.53% of its assets in AlloVir shares.

ALVR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	AlloVir	1.43%	49.12%	49.45%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Artal group	6.60M	5.75%	$4.77M
Gilead sciences	16.64M	0.63%	$6.99M
Blackrock	634.02K	0.55%	$458.59K
Northern trust	437.33K	0.38%	$316.32K
Siren	6.60M	0.25%	$2.77M
Millennium management	3.03M	0.11%	$1.27M
Vanguard group	2.65M	0.10%	$1.11M
Redmile group	1.91M	0.07%	$801.35K
Morgan stanley	69.95K	0.06%	$50.60K
Raymond james financial services advisors	60.50K	0.05%	$43.76K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Gilead sciences	16.64M	0.45%	$6.99M
Ecor1 capital	408.69K	0.15%	$3.95M
Siren	6.60M	0.12%	$2.77M
Artal group	6.60M	0.12%	$4.77M
Redmile group	1.91M	0.06%	$801.35K
Bml capital management	184.25K	0.05%	$77.38K
Tang capital management	552.26K	0.02%	$231.95K
Rbf capital	400.00K	0.01%	$168.00K
Samsara biocapital	82.34K	0.00%	$34.58K
Point72 asia (singapore) pte.	26.89K	0.00%	$11.29K

Top Buyers

Holder	Shares	% Assets	Change
Gilead sciences	16.64M	0.45%	16.64M
Tang capital management	552.26K	0.02%	552.26K
Woodline partners lp	451.86K	0.00%	451.86K
Squarepoint ops	337.94K	0.00%	337.94K
Ubs group	125.51K	-	123.29K

Top Sellers

Holder	Shares	% Assets	Change
Octagon capital advisors lp	-	-	-11.20M
Ecor1 capital	408.69K	0.15%	-10.89M
Blackrock	634.02K	-	-2.75M
Irenic capital management lp	-	-	-2.58M
American group	-	-	-1.15M

New Positions

Holder	Shares	% Assets	Change	Value
Gilead sciences	16.64M	0.45%	16.64M	$6.99M
Tang capital management	552.26K	0.02%	552.26K	$231.95K
Woodline partners lp	451.86K	0.00%	451.86K	$189.78K
Squarepoint ops	337.94K	0.00%	337.94K	$141.94K
Bnp paribas arbitrage, snc	74.96K	-	74.96K	$31.48K

Sold Out

Holder	Change
Nisa investment advisors	-8.00
Nelson, van denburg & campbell wealth management group	-9.00
Srs capital advisors	-451.00
Avion wealth	-683.00
Eversource wealth advisors	-695.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	48	-22.58%	38,021,488	-15.27%	1	0.09%	20	150.00%	15	-50.00%
Sep 30, 2024	61	-15.28%	44,870,371	-4.15%	38	2.33%	9	-68.97%	30	20.00%
Jun 30, 2024	72	-10.00%	46,811,085	-5.04%	40	2.18%	29	-17.14%	25	-10.71%
Mar 31, 2024	80	-4.76%	49,295,982	18.12%	43	3.22%	35	-27.08%	28	40.00%
Dec 31, 2023	84	-10.64%	41,733,393	-22.29%	36	1.14%	48	-9.43%	20	-9.09%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.77M	1.53%	-1.00
Vanguard Total Stock Mkt Idx Inv	77.03K	1.53%	-
Vanguard Institutional Extnd Mkt Idx Tr	37.33K	0.74%	-
A4Investments SICAV SIF ACCI IlanaA2EURH	13.83K	0.27%	13.83K
Fidelity Extended Market Index	12.01K	0.24%	-77.00
Vifag 2002 SICAV	8.70K	0.17%	1.00
Fidelity VIP Disciplined Small Cap Init	7.81K	0.15%	1.00
NT R2000 Value Index Fund - NL	138.54K	0.12%	-11.26K
BlackRock Extended Equity Market K	137.74K	0.12%	-58.00
Extended Equity Market Fund K	135.87K	0.12%	-1.87K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 21, 2025	Sinha Vikas	See Remarks	Sell	$3.05K
Feb 21, 2025	Hagen Brett R	Chief Accounting Officer	Sell	$967.28
Feb 21, 2025	Miller Edward	General Counsel	Sell	$1.07K
Jan 23, 2025	Miller Edward	General Counsel	Sell	$444.33
Jan 23, 2025	Miller Edward	General Counsel	Sell	$49.70

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	19
2024 Q3	-	20
2024 Q2	-	20
2024 Q1	-	18
2023 Q4	-	13

ALVR Ownership FAQ

Who Owns AlloVir?

AlloVir shareholders are primarily institutional investors at 1.43%, followed by 49.12% insiders and 49.45% retail investors. The average institutional ownership in AlloVir's industry, Biotech Stocks , is 68.48%, which AlloVir falls below.

Who owns the most shares of AlloVir?

AlloVir’s largest shareholders are Artal group (6.6M shares, 5.75%), Gilead sciences (16.64M shares, 0.63%), and Blackrock (634.02K shares, 0.55%). Together, they hold 6.93% of AlloVir’s total shares outstanding.

Does Blackrock own AlloVir?

Yes, BlackRock owns 0.55% of AlloVir, totaling 634.02K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 458.59K$. In the last quarter, BlackRock decreased its holdings by -2.752M shares, a -81.27% change.

Who is AlloVir’s biggest shareholder by percentage of total assets invested?

Gilead sciences is AlloVir’s biggest shareholder by percentage of total assets invested, with 0.45% of its assets in 16.64M AlloVir shares, valued at 6.99M$.

Who is the top mutual fund holder of AlloVir shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of AlloVir shares, with 1.53% of its total shares outstanding invested in 1.77M AlloVir shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools